Literature DB >> 1968351

Mass spectrometric assay for determination of pancuronium and vecuronium in biological fluids utilizing the moving belt introduction system.

T R Baker1, P Vouros, D Rindgen, J A Martyn.   

Abstract

An assay for the determination of the neuromuscular blocking agents pancuronium bromide and vecuronium bromide in plasma or urine has been developed. This method is based on syringe application of sample extracts to the moving belt surface and single metastable transition monitoring of the elimination of acetic acid from the ion of m/z 543 during chemical ionization. The analysis shows good linearity over three orders of magnitude and is capable of analyzing for the compounds below the 5 ng ml-1 level. The assay has been used in preliminary pharmacokinetic studies of the biological fluids of surgical patients. The utility of the method for simultaneous determination of the deacetylated metabolites of these two drugs has also been investigated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968351     DOI: 10.1002/bms.1200190204

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  3 in total

1.  An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument.

Authors:  Kevin D Ballard; William E Vickery; Loan T Nguyen; Francis X Diamond; Fredric Rieders
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-02       Impact factor: 3.109

2.  A modification of the kinetic determination of pancuronium bromide based on its inhibitory effect on cholinesterase.

Authors:  V P Stankov-Jovanovic; S D Nikolic-Mandic; Lj M Mandic; V D Mitic
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Stability indicating liquid chromatography method for the analysis of Vecuronium bromide: study of the degradation profile.

Authors:  Mohamed K Abd Elrahman; Ola M El Houssini; Diana K Fahem; Hala E Zaazaa
Journal:  Heliyon       Date:  2020-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.